Abiopharma

🔍 Green Park & Golf Ventures II, LLC (Executive)

Company: Mobia Medical, Inc. (MOBI)

Report Date: 2026-05-11

Detailed Transactions and Holdings:

• Acquired 22,568 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | shares_owned_after: 22,568.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 16,364 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | shares_owned_after: 38,932.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 8,333 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | shares_owned_after: 47,265.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Acquired 25,991 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | shares_owned_after: 25,991.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Acquired 20,833 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | shares_owned_after: 46,824.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Acquired 33,333 shares of Common Stock at $15.0 per share (Direct)
  Date: 2026-05-11 | Code: P | equity_swap_involved: false | shares_owned_after: 80,157.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 464,489 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | shares_owned_after: 464,489.00 | transaction_form_type: 4 | Footnotes: F3, F5
• Acquired 23,255 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | shares_owned_after: 23,255.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Acquired 23,255 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: X | equity_swap_involved: false | shares_owned_after: 46,510.00 | transaction_form_type: 4 | Footnotes: F7, F6
• Acquired 26,988 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | shares_owned_after: 26,988.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Acquired 24,416 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | shares_owned_after: 51,404.00 | transaction_form_type: 4 | Footnotes: F3, F8
• Acquired 311,112 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | shares_owned_after: 311,112.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 22,568 shares of Series E-2 Preferred Stock (Derivative)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Sold 16,364 shares of Series F Preferred Stock (Derivative)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Sold 8,333 shares of Convertible Notes (Derivative)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3, F2
• Sold 25,991 shares of Series E-1 Preferred Stock (Derivative)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F4
• Sold 20,833 shares of Convertible Notes (Derivative)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3, F4
• Sold 464,489 shares of Convertible Notes (Derivative)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3, F5
• Sold 23,255 shares of Series B Preferred Stock (Derivative)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F6
• Sold 23,255 shares of Series B Preferred Warrant (Derivative)
  Date: 2026-05-11 | Code: X | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F7, F7, F7, F7, F6
• Sold 26,988 shares of Series B Preferred Stock (Derivative)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F8
• Sold 24,416 shares of Convertible Notes (Derivative)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3, F8
• Sold 311,112 shares of Series E-1 Preferred Stock (Derivative)
  Date: 2026-05-11 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F9

Footnotes:

• F1: Each share of Series B Preferred Stock, Series D Preferred Stock, Series F Preferred Stock, Series E-1 Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.
• F2: The securities are held by GPG SC, LLC ("SC").
• F3: The Convertible Notes converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.
• F4: The securities are held by GPG WG, LLC ("WG").
• F5: The securities are held by GPG MTIF, LLC ("MTIF").
• F6: The securities are held by Micro TI Investment 2, LLC ("Micro TI 2").
• F7: Common stock issued upon exercise of warrant to purchase Series B Preferred Stock. The warrants have an exercise price of $3.73744 per share. Unless exercised earlier, the warrants will expire December 14, 2032.
• F8: The securities are held by Micro TI Investment, LLC ("Micro TI").
• F9: The securities are held by MTI 20 Investment, LLC ("MTI 20").
• F10: Green Park & Golf Ventures II, LLC ("GPG Ventures II") is the managing member of each of SC, WG, MTIF, Micro TI, Micro TI 2, and MTI 20. Clay M. Heighten, MD, Carl D. Soderstrom and Gilbert G. Garcia II are managers of GPG Ventures II and share voting and dispositive power with respect to the shares held by each of SC, WG, MTIF, Micro TI, Micro TI 2, and MTI 20, and as a result may be deemed to beneficially own such securities.
• REMARKS: This Form 4 is the third of five Forms 4 filed relating to the same event. Combined, the five Forms 4 report the holdings for the following reporting persons: Green Park & Golf Ventures II, LLC, Clay M. Heighten, MD, Carl D. Soderstrom, Gilbert G. Garcia II, GPG BFH, LLC, GPG Charles & Potomac, LLC, GPG Dais, LLC, GPG GR, LLC, GPG Healthcare Opportunities Fund II, LLC, GPG Healthcare Opportunities Fund, LLC, GPG JCT, LLC, GPG MTI 22, LLC, GPG MTI 25, LLC, GPG MOBI, LLC, GPG MTI 3-17 Investment, LLC, GPG PHL, LLC, GPG RM Investment, LLC, GPG SC, LLC, GPG WG, LLC, GPG MTIF, LLC, Micro TI Investment 2, LLC, Micro TI Investment, LLC, MTI 20 Investment, LLC, MTI 2015 Investment, LLC, HTX MCT1 0320 Investment, LLC, HTX MCT2 0221 Investment, LLC, HTX MCT3 0322 Investment, LLC, HTX MCT4 0226 Investment, LLC and Green Park & Golf Ventures - Houston, LLC. The Form 4 has been split into five filings because there are more than 10 reporting persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 reporting persons.